Malaysia-based pharma company Pharmaniaga Berhad (Pharmaniaga) is planning to bring its products into mainland China through a partnership with JD.com, one of China’s largest e-commerce platforms. The company has signed a memorandum of understanding (MoU) with JD.com subsidiary JDMAS Commerce Sdn Bhd to commercialize its over-the-counter (OTC) products, with plans to expand to pharmaceutical products in the future.
Partnership Details
Under the MoU, JDMAS will be responsible for registering, importing, distributing, and marketing Pharmaniaga’s products in China. The initial focus will be on listing Pharmaniaga’s leading OTC brands, including Citrex Vitamin C, Citrex Gummies, Baraka, Habbatus Sauda, Sweet Royale, and other OTC products, in the Malaysian Pavilion of JD.com by January 2023.
Market Expansion and Revenue Projections
Pharmaniaga views this partnership as a major step in internationalizing its operations and gaining access to JD.com’s over 500 million users. The company forecasts that current OTC revenues will increase by 100%-150% in the first year, with total revenues reaching USD 30 million by 2025 as additional products are launched. Specific financial terms of the deal were not disclosed.-Fineline Info & Tech
